Debilur 20 mg Tablets: Enhancing Mobility for Peripheral Arterial Disease

Debilur 20 mg Tablets, produced by Spimaco, are a prescription-only medication formulated to improve symptoms associated with intermittent claudication, a common manifestation of peripheral arterial disease (PAD). This condition is characterized by leg pain and cramping during exercise, which is relieved by rest, due to reduced blood flow to the legs.

The active ingredient in Debilur is Cilostazol, a phosphodiesterase type 3 (PDE3) inhibitor. Cilostazol works through a dual mechanism:

• It dilates arteries, particularly those in the legs, thereby enhancing blood flow to the affected muscles.
• It inhibits platelet aggregation, reducing the risk of blood clot formation and improving microcirculation.

By alleviating leg pain and increasing the maximum walking distance, Debilur helps restore mobility and significantly improves the quality of life for individuals suffering from intermittent claudication. As a prescription medication, its use should always be under the guidance and supervision of a healthcare professional.

Benefits of Debilur 20 mg Tablets

• Improves walking distance and physical performance in individuals with intermittent claudication.
• Significantly alleviates leg pain and cramping experienced during walking.
• Enhances blood circulation to the legs and feet, vital for muscle function.
• Reduces the risk of platelet aggregation, supporting healthier blood flow.
• Contributes to the overall management of peripheral arterial disease symptoms.

How to Use Debilur 20 mg Tablets

Debilur 20 mg Tablets are a prescription medication. Always follow the specific instructions provided by your doctor or pharmacist. General guidance often includes:

1. Your physician will determine the appropriate dosage and frequency based on your medical condition and response to treatment.
2. Debilur tablets are typically taken orally, usually twice daily, approximately 30 minutes before breakfast and dinner, or at least 2 hours after a meal.
3. Swallow the tablet whole with a glass of water; do not crush, chew, or break it.
4. Consistency is key; try to take your medication at the same times each day.
5. Do not stop taking Debilur without consulting your doctor, even if your symptoms improve.

Caution & Warnings

• Debilur is a prescription-only medication and should only be used under medical supervision.
• Patients with heart failure of any severity should not use Cilostazol, as it may worsen the condition.
• Exercise caution in patients with a history of bleeding disorders or those taking other medications that increase bleeding risk (e.g., anticoagulants, antiplatelets), due to the antiplatelet effect of Cilostazol.
• Inform your doctor about all other medications, supplements, and herbal products you are taking, as drug interactions can occur, particularly with CYP3A4 inhibitors (e.g., grapefruit juice, diltiazem, erythromycin, ketoconazole) and CYP2C19 inhibitors (e.g., omeprazole).
• Not recommended for use during pregnancy or breastfeeding unless clearly necessary and advised by a physician.
• Possible side effects may include headache, diarrhea, abnormal stools, peripheral edema, palpitations, and dizziness. Consult your doctor if these or any other adverse effects persist or worsen.
• Regular monitoring by your doctor is important to assess treatment effectiveness and manage potential side effects.

Ingredients

• Active Ingredient: Cilostazol 20 mg
• Excipients: Contains other inactive ingredients as per pharmaceutical formulation.

Product Details

• Brand: Spimaco
• Manufacturer: Spimaco
• Form: Tablet
• Drug Type: Prescription Only Medicine (POM)
• Primary Use: Treatment of intermittent claudication symptoms in peripheral arterial disease.

Storage Conditions

Store Debilur 20 mg Tablets in a cool, dry place, typically below 30°C (86°F).

Protect from moisture and direct light.

Keep out of reach of children.